Literature DB >> 28665179

Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency.

H Nihira1, K Nakagawa1, K Izawa1, T Kawai1, T Yasumi1, R Nishikomori1, M Nambu2, A Miyagawa-Hayashino3, T Nomura4, K Kabashima4, M Ito5, S Iwaki-Egawa5, Y Sasahara6, M Nakayama7, T Heike1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28665179     DOI： 10.1080/03009742.2017.1324912

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  6 in total

Review 1.  Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.

Authors:  Benzeeta Pinto; Prateek Deo; Susmita Sharma; Arshi Syal; Aman Sharma
Journal:  Clin Rheumatol       Date:  2021-03-31       Impact factor: 2.980

Review 2.  Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes.

Authors:  Avinash Jain; Durga Prasanna Misra; Aman Sharma; Anupam Wakhlu; Vikas Agarwal; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2017-10-14       Impact factor: 3.580

Review 3.  Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.

Authors:  Isabelle Meyts; Ivona Aksentijevich
Journal:  J Clin Immunol       Date:  2018-06-27       Impact factor: 8.317

Review 4.  Tocilizumab therapy for persistent high-grade fever in systemic lupus erythematosus: two cases and a literature review.

Authors:  Ma Chaoyi; Bikash Shrestha; Li Hui; Ding Qiujin; Fu Ping
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

Review 5.  Recent advances in primary immunodeficiency: from molecular diagnosis to treatment.

Authors:  Giorgia Bucciol; Isabelle Meyts
Journal:  F1000Res       Date:  2020-03-19

Review 6.  The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.

Authors:  Jennifer Lee Kendall; Jason Michael Springer
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.